Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European stocks edge higher ahead of key PMI data, ECB minutes

Published 23/11/2023, 07:06 pm
Updated 23/11/2023, 07:06 pm
© Reuters.

Investing.com - European stock markets edged higher Thursday, as investors awaited the minutes from the October ECB meeting as well as the latest regional business activity data.

At 03:05 ET (08:05 GMT), the DAX index in Germany traded 0.1% higher, the CAC 40 in France traded up 0.2% and the FTSE 100 in the U.K. also rose 0.1%.

ECB minutes, PMI data due

The key debate raging in the markets is have the major central banks finished with interest rates to curb inflation, and if so when will they start cutting.

This debate is likely to be informed Thursday by the release of the minutes of the European Central Bank's October meeting, the gathering that saw the ECB snap an unprecedented streak of 10 consecutive rate hikes.

Comments from policy makers following the meeting have tended to muddy the waters, with dovish comments from Governing Council member Mario Centeno contrasting with President Christine Lagarde warning against premature celebration. 

Meanwhile, the forward-looking flash November PMIs are also due for release, and are likely to suggest economic activity is contracting in the eurozone.

Surprise Dutch election win

Investors will also likely contemplate the likely implications of the victory of Dutch anti-EU far-right populist Geert Wilders in parliamentary elections in the Netherlands overnight.

Additionally, British finance minister Jeremy Hunt announced tax cuts for workers as part of the annual Autumn Statement, while also attempting to  give businesses permanent investment incentives in an attempt to give the struggling U.K. economy a boost.

Novo Nordisk (CSE:NOVOb) invests in France 

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In the corporate sector, activity is likely to be limited with the U.S. celebrating the Thanksgiving holiday, but Novo Nordisk (NYSE:NVO) could get a boost with French President Emmanuel Macron set to inaugurate a new investment by the  Danish pharmaceutical company in France.

The investment will be based in Chartres, west of Paris, where Novo already employs nearly 2,000 people.

Crude deepens losses on OPEC+ uncertainty

Oil prices fell Thursday, adding to the previous session’s sharp losses as the unexpected delay in an upcoming OPEC+ meeting spurred uncertainty over the extent of the intended reduction in supplies by the producer group. 

By 03:05 ET, the U.S. crude futures traded 0.7% lower at $76.59 a barrel, while the Brent contract dropped 0.8% to $81.32 a barrel. Both contracts fell at least 4% on Wednesday.

The Organization of the Petroleum Exporting Countries and allies including Russia delayed to Nov. 30 a ministerial meeting, originally scheduled for Sunday, where they were expected to discuss oil output cuts.

This has prompted speculation that the group of major producers were struggling to agree on output levels and hence possible reductions going forward.

Adding to the negativity, official data showed U.S. crude stocks jumped by 8.7 million barrels last week, much more than expected, and the fourth straight week of builds for U.S. inventories, indicating that oil supplies remained robust. 

Additionally, gold futures rose 0.3% to $1,997.95/oz, while EUR/USD traded 0.2% higher at 1.0912.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.